Buyout giant EQT has agreed to buy into €2.2bn-managing European life science venture capital firm LSP for €450m to strengthen its position in the healthcare sector. A potential earn-out payment of €25m will also be made if certain short-term fundraising targets are met, the firm said.
The post EQT to buy €2.2bn-managing life science VC firm LSP for €450m first appeared on AltAssets Private Equity News.
